Help us: Donate
Follow us on:
×

Tag: Vera Gorbunova

August 01, 2019
The July Journal Club hosted by Dr. Oliver Medvedik looked at the recent SIRT6 evolutionary biology paper by Dr. Vera Gorbunova and collaborators, showing a relationship between enhanced SIRT6 function and longevity. The study took a deep dive into SIRT6 in multiple species and how it appears to support longevity to a lesser or greater...
July 30, 2019
Ending Age-Related Diseases 2019 is over, and the dust is starting to settle after what can only be described as a hugely successful event for our organization. This was our second year of running a conference, and once more, we focused on the research and investment areas of rejuvenation biotechnology. Totally sold out We wish...
July 17, 2019
The Journal Club hosted by Dr. Oliver Medvedik returns for July and takes a look at the new SIRT6 evolutionary biology paper by Dr. Vera Gorbunova and collaborators, showing a relationship between enhanced SIRT6 function and longevity. Join us at 13:00 EDT on our Facebook channel where we will be livestreaming the show and discussing...
April 24, 2019
Sirtuins have long been implicated in playing a role in the longevity of various species, including our own, and researchers at the University of Rochester have now discovered more supporting evidence that they do. What are sirtuins? Sirtuins are a family of proteins that facilitate cellular function and have long been known to play a...
October 30, 2018
Today, we have an interview with Dr. Vera Gorbunova, who talks about the current understanding of the mechanisms of longevity and genomic stability in exceptionally long-lived mammals and how this knowledge might be used to create therapies to extend healthy human lifespan. Dr. Vera Gorbunova is an endowed Professor of Biology at the University of...
May 25, 2018
BRINGING REJUVENATION BIOTECHNOLOGY AND INVESTORS TOGETHER At the Frederick P. Rose Auditorium, Cooper Union in New York City, we will be hosting a special one-day conference focused on aging research and biotech investment. Developing therapies from initial concepts, through clinical testing, and ultimately to market takes a pipeline, and right now, that pipeline is being...